Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy) Global Clinical Trials Review 2024 [Yahoo! Finance]
Thermo Fisher Scientific Inc (TMO)
Last thermo fisher scientific inc earnings: 4/22 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
ir.thermofisher.com/investors/investor-overview/default.aspx
Company Research
Source: Yahoo! Finance
Therapeutics, Thermo Fisher Scientific, Harmony Biosciences Holdings, Ovid Therapeutics and Sage Therapeutics. Dublin, Dec. 26, 2024 (GLOBE NEWSWIRE) -- The "Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy) - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's offering. The clinical trial report provides an overview of Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy) Clinical trials scenario. This report provides top line data relating to the clinical trials on Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy). The report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). The Clinical Trial Reports are generated using a pro
Show less
Read more
Impact Snapshot
Event Time:
TMO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TMO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TMO alerts
High impacting Thermo Fisher Scientific Inc news events
Weekly update
A roundup of the hottest topics
TMO
News
- Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, January 30, 2025 [Yahoo! Finance]Yahoo! Finance
- Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, January 30, 2025Business Wire
- $1.75 Bn Medical Filters Market to 2030: Rising Demand Spurred by Increased Focus on Sterile Healthcare Environments [Yahoo! Finance]Yahoo! Finance
- Minimal Residual Disease Testing Market Growth Trends 2025-2031: Growing Use of MRD Testing In Cases of Solid Tumors [Yahoo! Finance]Yahoo! Finance
- IVD Assay Development Market Size, Share, Forecast, & Trends Analysis, 2024-2031 - Stability Testing Set to be the Fastest-Growing Segment with an 8.1% CAGR Through 2031 [Yahoo! Finance]Yahoo! Finance
TMO
Earnings
- 10/23/24 - Beat
TMO
Sec Filings
- 1/2/25 - Form 4
- 1/2/25 - Form 4
- 1/2/25 - Form 4
- TMO's page on the SEC website